Company / Income Tax
TEVA PHARMACEUTICAL INDUSTRIES LTD Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$180.0M
FY2025
5-year range
-$643.0M / $676.0M
FY2021-FY2025
Trend
-126.6%
vs FY2024
Sector context
#199 of 204
Health Care
What the data says
Among 204 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the top 2% for income tax. Income Tax has fluctuated over the past 10 years, ranging from -$1.9B in FY2017 to $676M in FY2024.
Based on SEC 10-K filings.
-$180M in FY2025.
Improved from -$7M to -$180M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 204This company -$180.0M Sector average $118.7M
▼
-251.6% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 126.6% year-over-year.
- Ranks #199 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
- Lowest income tax in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$180.0M | -126.6% |
| FY2024 | $676.0M | +9757.1% |
| FY2023 | -$7.0M | +98.9% |
| FY2022 | -$643.0M | -404.7% |
| FY2021 | $211.0M | +225.6% |
| FY2020 | -$168.0M | +39.6% |
| FY2019 | -$278.0M | -42.6% |
| FY2018 | -$195.0M | +89.9% |
| FY2017 | -$1.9B | -471.0% |
| FY2016 | $521.0M | -17.8% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026